Profilin-PTEN interaction suppresses NF-κB activation via inhibition of IKK phosphorylation

Adeel H Zaidi1, Sunil K Manna2

  • 1Laboratory of Immunology, Centre for DNA Fingerprinting & Diagnostics, Nampally, Hyderabad 500 001, Telangana, India Graduate Studies, Manipal University, Manipal 576104, Karnataka, India.

The Biochemical Journal
|January 21, 2016
PubMed

Insights

Profilin, a tumor suppressor, inhibits nuclear factor-kappa B (NF-κB) signaling by interacting with PTEN. This interaction suppresses tumor growth and promotes cell death by regulating NF-κB-dependent genes.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The tumor suppressor activity of Profilin is not fully understood at the molecular level.
  • Nuclear transcription factor-kappa B (NF-κB) signaling pathways are implicated in cell proliferation and tumorigenesis.

Purpose of the Study:

  • To elucidate the molecular mechanism underlying Profilin's tumor suppressor activity.
  • To investigate the role of Profilin in the regulation of NF-κB signaling pathways.

Main Methods:

  • Cellular assays to measure NF-κB activity, including IκBα kinase (IKK) activity, IκBα and p65 protein levels, and nuclear NF-κB DNA binding.
  • Co-localization and co-immunoprecipitation (Co-IP) studies to assess protein-protein interactions.
  • Analysis of NF-κB-dependent gene expression involved in cell cycle progression and cell death.

Main Results:

  • Profilin overexpression led to decreased basal IKK activity, increased cytoplasmic IκBα and p65, and reduced nuclear NF-κB DNA binding.
  • Profilin interacts with phosphatase and tensin homologue (PTEN), protecting it from degradation.
  • PTEN, stabilized by Profilin, suppresses NF-κB signaling by maintaining IKK in a low phosphorylated state.

Conclusions:

  • Profilin enhances tumor suppressor activity by inhibiting NF-κB signaling through interaction with PTEN.
  • This mechanism leads to reduced activation of NF-κB by various inducers and promotes cell death by repressing oncogenic NF-κB-dependent genes.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K